alexa Inflammatory Mediators in Diabetic Neuropathy
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Inflammatory Mediators in Diabetic Neuropathy

Natalie M. Wilson and Douglas E. Wright*

Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA

*Corresponding Author:
Douglas Wright, PhD
Department of Anatomy and Cell Biology
University of Kansas Medical Center
Kansas City, KS 66160, USA
Tel: 913-588-2713
Fax: 913-588-2710
E-mail: [email protected]

Received date: November 11, 2011; Accepted date: December 17, 2011; Published date: December 22, 2011

Citation: Wilson NM, Wright DE (2011) Inflammatory Mediators in Diabetic Neuropathy. J Diabetes Metab S5:004. doi:10.4172/2155-6156.S5-004

Copyright: © 2011 Wilson NM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Diabetic neuropathy (DN) is the most common complication of diabetes mellitus, resulting in high health care costs and greatly affecting the quality of life of patients. The mechanism(s) responsible for the development of DN is currently unclear, but is likely multifactoral. While a great deal is still unknown about the mediators responsible for the development of DN, current knowledge of other neuropathic conditions suggest the involvement of a number of inflammatory mediators such as interleukins and chemokines. This review will outline the current literature of a number of inflammatory mediators in both human and rodent studies. As there is currently no therapeutic treatment for DN, this review will also provide an overview of therapeutics targeting inflammation and the ability of these therapies to improve the symptoms of DN.

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version